Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

被引:65
|
作者
Quarantelli, M
Ciarmiello, A
Morra, VB
Orefice, G
Larobina, M
Lanzillo, R
Schiavone, V
Salvatore, E
Alfano, B
Brunetti, A
机构
[1] CNR, Ist Biostruct & Bioimmagini, I-80131 Naples, Italy
[2] IRCCS, Fdn G Pascale, Dept Diagnost Imaging, Naples, Italy
[3] Univ Naples Federico II, Dept Neurog Sci, Naples, Italy
[4] Univ Naples Federico II, Dept Diagnost Imaging, Naples, Italy
关键词
relapsing-remitting multiple sclerosis; MRI; brain atrophy; segmentation; brain volume;
D O I
10.1016/S1053-8119(02)00018-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of this study was to simultaneously measure in vivo volumes of gray matter (GM), normal white matter (WM), abnormal white matter (aWM), and cerebro-spinal fluid (CSF), and to assess their relationship in 50 patients with relapsing-remitting multiple sclerosis (RR-MS) (age range, 21-59; mean EDSS, 2.5; mean disease duration, 9.9 years), using an unsupervised multiparametric segmentation procedure applied to brain MR studies. Tissue volumes were normalized to total intracranial volume providing corresponding fractional volumes (fGM, faWM, fWM, and fCSF), subsequently corrected for aWM-related segmentation inaccuracies and adjusted to mean patients' age according to age-related changes measured in 54 normal volunteers (NV) (age range 16-70). In MS patients aWM was 23.8 +/- 29.8 ml (range 0.4-138.8). A significant decrease in fGM was present in MS patients as compared to NV (49.5 3.2% vs 53.3 +/- 2.1%; P < 0.0001), with a corresponding increase in fCSF (13.0 +/- 3.8% vs 9.1 +/- 2.4%; P < 0.0001). No difference could be detected between the two groups for fWM (37.5 +/- 2.6% vs 37.6 +/- 2.2%). faWM correlated inversely with fGM (R = -0.434, P < 0.001 at regression analysis), and directly with fCSF (R 0.473, P < 0.001), but not with fWM. There was a significant correlation between disease duration and EDSS, while no relationship was found between EDSS or disease duration and fractional volumes. Brain atrophy in RR-MS is mainly related to GM loss, which correlates with faWM. Both measures do not appear to significantly affect EDSS, which correlates to disease duration. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:360 / 366
页数:7
相关论文
共 50 条
  • [41] Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Tizio, Santiago
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (08) : 574 - 577
  • [42] Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis
    Sanchez, M. P.
    Nieto, A.
    Barroso, J.
    Martin, V.
    Hernandez, M. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (10) : 1091 - 1099
  • [43] Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis
    Gomez, Pablo Rodriguez de Vera
    Muros, Mariola Mendez
    Cuadro, Alberto Torres
    de Miera, Francisco Javier Toyos Saenz
    Ruiz, Rocio Lopez
    Vazquez, Raquel Guerrero
    Gonzalez, Juan Jesus Garcia
    Hermosilla, Antonio Manuel Garrido
    Hernandez, Tomas Martin
    JOURNAL OF NEUROLOGY, 2024, 271 (01) : 486 - 496
  • [44] Novel and imminently emerging treatments in relapsing-remitting multiple sclerosis
    Oh, Jiwon
    O'Connor, Paul W.
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (03) : 230 - 236
  • [45] Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis
    Brown, J. William L.
    Coles, Alasdair J.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 131 - 138
  • [46] Diffusely Abnormal White Matter, T2 Burden of Disease, and Brain Volume in Relapsing-Remitting Multiple Sclerosis
    Vertinsky, Alexandra T.
    Li, David K. B.
    Vavasour, Irene M.
    Miropolsky, Vladislav
    Zhao, Guojun
    Zhao, Yinshan
    Riddehough, Andrew
    Moore, G. R. Wayne
    Traboulsee, Anthony
    Laule, Cornelia
    JOURNAL OF NEUROIMAGING, 2019, 29 (01) : 151 - 159
  • [47] Interferon β treatment in relapsing-remitting multiple sclerosis.: A review
    Grigoriadis, N
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) : 251 - 258
  • [48] Pausing and fluency in speech of patients with relapsing-remitting multiple sclerosis
    Bona, Judit
    CLINICAL LINGUISTICS & PHONETICS, 2024, 38 (04) : 332 - 344
  • [49] Cortical diffusion kurtosis imaging and thalamic volume are associated with cognitive and walking performance in relapsing-remitting multiple sclerosis
    Nygaard, Mikkel K. E.
    Langeskov-Christensen, Martin
    Dalgas, Ulrik
    Eskildsen, Simon F.
    JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3861 - 3870
  • [50] Beta-interferons in the therapy of relapsing-remitting multiple sclerosis
    Klimová, E
    Szilasiová, J
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2003, 66 (05) : 343 - +